Be the first person to write a business review for InSight Health Services Holdings Corp

Ironare are committed to the development of successful human medicines. Drugmaking is not a statistical event, nor simply a high-throughput industrialized pursuit. Our team is forging a process for creating and developing novel drug candidates that integrates the most successful drugmaking practices of the past and the best of today's cutting-edge technologies. Our efficient discovery and development processes, focused on important human needs, are generating a robust pipeline.

Lab21 supports healthcare providers and the pharmaceutical and biotechnology industries with technically advanced testing services. The Lab21 team’s experience and know-how is coupled with a rapidly growing portfolio of molecular and viral diagnostics, plus pharmacogenetic and patient profiling tests, which all use cutting-edge technology. This unique combination adds value to early stage drug development, clinical trials and regulatory processes in pharmaceutical industry – and directly to clinicians or healthcare providers as they treat and monitor patients.

Laboratory Corporation of America Holdings, together with its subsidiaries, operates as an independent clinical laboratory company in the United States. The company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease, as well as specialty testing services. Its routine tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, HIV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

Med BioGene Inc. (MBI: TSX Venture) is a life science company focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests.The company develops gene expression assays (lab tests that examine organic samples on a molecular level) used to examine cancerous tumors. Its primary offering, LungExpress DX, is a late-stage assay candidate used to test lung cancer tumors in order to assist physicians in determining treatment options for their patients. The biotech firm's pipeline also contains similar methods for testing lymphoma and cardiovascular disease. Med BioGene filed for a US IPO in 2010, but fell short of funding and announced plans to review strategic alternatives later that year, including a possible sale or liquidation of the company.

MEDTOX is a full service laboratory, committed to providing clients with the services and solutions they need to run successful testing programs. For 25 years we have continually added new assays, support programs, new products and full laboratory divisions to meet the needs of our clients. MEDTOX services include.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.